Tenet Healthcare Corporation (NYSE:THC) Receives Average Rating of “Moderate Buy” from Analysts

Tenet Healthcare Corporation (NYSE:THC) has been given an average rating of “Moderate Buy” by the twenty-two ratings firms that are presently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $247.6667.

A number of brokerages have commented on THC. Jefferies Financial Group increased their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. UBS Group increased their target price on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. Weiss Ratings upgraded Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Finally, Truist Financial boosted their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th.

Tenet Healthcare Stock Up 0.6%

Shares of NYSE THC opened at $229.56 on Monday. The stock has a market cap of $19.96 billion, a P/E ratio of 14.82, a PEG ratio of 1.13 and a beta of 1.45. The business’s fifty day simple moving average is $201.87 and its 200-day simple moving average is $197.69. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $235.77. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare’s revenue was up 8.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, equities analysts predict that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insider Activity

In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company’s stock, valued at $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. Triumph Capital Management purchased a new position in Tenet Healthcare during the 3rd quarter worth approximately $25,000. Activest Wealth Management acquired a new stake in shares of Tenet Healthcare in the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new position in shares of Tenet Healthcare in the 4th quarter valued at $29,000. William B. Walkup & Associates Inc. purchased a new stake in Tenet Healthcare in the 3rd quarter valued at $32,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare in the 2nd quarter valued at $35,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.